CORC  > 清华大学
一次性使用树脂吸附柱治疗尿毒症的临床观察
卢方平 ; 卢照翾 ; LU Fangping ; LU Zhaoxuan.
2010-06-09 ; 2010-06-09
关键词血液灌流 血液透析 尿毒症 中分子毒素 Hemoperfusion Hemodialysis Uremia Middle molecular substances R692.5
其他题名The clinical study of combined hemodialysis-hemoperfusion in chronic uremia
中文摘要目的探讨1次性使用树脂吸附柱治疗尿毒症患者的疗效与安全性。方法维持性血液透析患者31例,采用血液灌流与血液透析(HP/HD)联合治疗方法与常规血液透析(HD)方法对比(自身对照)。治疗前后检测中分子物质(MMS)、血尿素、肌酐、白蛋白、血细胞及临床症状。结果树脂吸附柱治疗血液透析患者能显著清除尿毒症患者体内的中分子物质,单次使用治疗2hMMS平均下降25.0%,最高达44.4%。而普通透析对MMS无多大影响,两者差异具有显著性(P<0.001)。同时患者的睡眠、食欲、皮肤瘙痒有不同程度的改善。未发生其他任何不良事件和副作用。结论作为MMS的清除治疗措施,1次性使用树脂吸附柱临床使用安全、疗效可靠,无毒副反应。; objective To investigate the effect and safety of combined hemodialy-sis- resin hemoperfusion in uremia. Methods Thirty-one uremia patients were treated withcombined hemodialysis-resin hemoperfusion. Middle molecular substances(MMS),urea and crea-tinine were detected before and after the treatment. Meanwhile, we compared the effect ofcombined hemodialysis- resin hemoperfusion procedure with conventional hemodialysis inuremic toxin clearance. Results MMS was reduced significantly in combined hemodialysis-hemoperfusion procedure (P <0.001). Compared with conventional hemodialysis, a combinationof hemoperfusion and hemodialysis had a better effect in MMS clearance (P <0.001). Meanwhile,some clinical conditions (appetite, pruritus, insomnia) improved. We did not found anyadverse effect. Conclusion Resin hemoperfusion can effectively clean MMS and was confirmedto be a safe and risk-free procedure.
语种中文 ; 中文
内容类型期刊论文
源URL[http://hdl.handle.net/123456789/58875]  
专题清华大学
推荐引用方式
GB/T 7714
卢方平,卢照翾,LU Fangping,等. 一次性使用树脂吸附柱治疗尿毒症的临床观察[J],2010, 2010.
APA 卢方平,卢照翾,LU Fangping,&LU Zhaoxuan..(2010).一次性使用树脂吸附柱治疗尿毒症的临床观察..
MLA 卢方平,et al."一次性使用树脂吸附柱治疗尿毒症的临床观察".(2010).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace